Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 650x65px
All >

News > Northern Europe

Please find below news about Denmark, Estonia, Finland, Iceland, Ireland, Latvia, Lithuania, Norway, Sweden and the UK as well as about organisations from these countries.

Total search results: 4989 | Ordered by Date (descending)
1 2 3 ... 48 49 50  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Clarivate Analytics plc. (1/17/20). "Press Release: Clarivate Analytics to Acquire Decision Resources Group, Creating a Leading Global Provider of Data-Driven Solutions to the Life Sciences Industry". London & Philadelphia, PA. 2020-01-17
ERS Genomics Ltd.. (1/17/20). "Press Release: ERS Genomics Provides Comment on EPO Technical Board of Appeal Decision Upholding Revocation of Broad Institute CRISPR Patent". Dublin. 2020-01-17
Charles River Laboratories International, Inc.. (1/16/20). "Press Release: Charles River Laboratories and Fios Genomics Form a Strategic Alliance to Provide Bioinformatics-driven Drug Discovery and Safety Assessment". Wilmington, MA & Edinburgh. 2020-01-16
Vivoryon Therapeutics AG. (1/14/20). "Press Release: Vivoryon Therapeutics and Nordic Bioscience Enter Research and Development Collaboration". Halle (Saale) & Herlev. 2020-01-14
Adaptimmune Therapeutics plc. (1/14/20). "Press Release: Astellas and Adaptimmune Enter into Agreement to Co-Develop and Co-Commercialize Stem-Cell Derived Allogeneic CAR-T and TCR T-Cell Therapies". Tokyo, Philadelphia, PA & Oxfordshire. 2020-01-14
ERS Genomics Ltd.. (1/13/20). "Press Release: ERS Genomics Licenses CRISPR Gene Editing Technology to Daiichi Sankyo to Support Internal Research and Development". Dublin. 2020-01-13
Alderaan Biotechnology S.A.S.. (1/9/20). "Press Release: Alderaan Biotechnology Raises €18.5m in Series A from Advent France Biotechnology (AFB) and Medicxi". Paris. 2020-01-09
Grey Wolf Therapeutics Ltd.. (1/9/20). "Press Release: Grey Wolf Completes £2.5 Million Series A2 Financing for Development of Therapies Targeting ERAP2". Oxford. 2020-01-09
Medicines Discovery Catapult, The. (1/9/20). "Press Release: Hearing Medicines Discovery Syndicate Launches to Fast-track the Development of Hearing Therapeutics". 2020-01-09
Bayer AG. (1/9/20). "Press Release: Bayer and Exscientia Collaborate to Leverage the Potential of Artificial Intelligence in Cardiovascular and Oncology Drug Discovery". Berlin. 2020-01-09
Avacta Group plc. (1/8/20). "Press Release: Avacta and Daewoong Pharmaceutical Form Immunotherapy Focused Joint Venture". Cambridge & Seoul. 2020-01-08
GlaxoSmithKline plc. (1/8/20). "Press Release: Deborah Waterhouse, CEO of ViiV Healthcare, to Join GSK Corporate Executive Team (CET)". London. 2020-01-08
Galecto Biotech AB. (1/7/20). "Press Release: Galecto and PharmAkea Merge to Create Strong Clinical-stage Company Developing First-in-Class Therapeutics in Fibrosis and Cancer". San Diego, CA & Copenhagen. 2020-01-07
PhoreMost Ltd.. (1/7/20). "Press Release: PhoreMost and Boehringer Ingelheim Enter Multi-project Drug Discovery Collaboration". Cambridge. 2020-01-07
MiNA Therapeutics Ltd.. (1/7/20). "Press Release: MiNA Therapeutics Announces Research Collaboration with AstraZeneca in Metabolic Diseases". London. 2020-01-07
ERS Genomics Ltd.. (1/7/20). "Press Release: ERS Genomics Announces Agreement with New England Biolabs to Commercialize CRISPR Gene Editing Tools and Reagents". Dublin & Ipswich, MA. 2020-01-07
Bicycle Therapeutics plc. (1/7/20). "Press Release: Bicycle Therapeutics and Cancer Research UK to Collaborate on Development of New Bicycle Immuno-oncology Candidate, BT7401". London, Cambridge & Boston, MA. 2020-01-07
Novo Holdings A/S. (1/6/20). "Press Release: Novo Holdings REPAIR Impact Fund Invests USD 12 Million in Mutabilis and IBT Vaccines and Provides Strategic Update". Copenhagen. 2020-01-06
Nabriva Therapeutics plc. (12/20/19). "Press Release: Nabriva Therapeutics Resubmits New Drug Application for Intravenous Contepo (fosfomycin) for Injection". Dublin. 2019-12-20
Nabriva Therapeutics plc. (12/20/19). "Press Release: Nabriva Therapeutics Announces $20 Million Registered Direct Offering". Dublin & King of Prussia, PA. 2019-12-20
Zelluna Immunotherapy AS. (12/19/19). "Press Release: Zelluna Immunotherapy Appoints Namir Hassan as Chief Executive Officer". Oslo. 2019-12-19
Bone Therapeutics S.A.. (12/19/19). "Press Release: Bone Therapeutics Announces the Appointment of Dr. Miguel Forte as CEO to Lead the Company into the Next Phase of Development". Gosselies. 2019-12-19
Genmab A/S. (12/19/19). "Press Release: Genmab and CureVac Enter Strategic Partnership to Develop mRNA-based Antibody Therapeutics". Copenhagen & Tübingen. 2019-12-19
Pathios Therapeutics Ltd.. (12/18/19). "Press Release: Pathios Closes US$8.8m Series A and Appoints Stuart Hughes as CEO". Oxford. 2019-12-18
Genomill Health. (12/18/19). "Press Release: Genomill Health Closes Investment Round to Expand Beta-testing with Liquid Biopsy Players". Turku. 2019-12-18
Edinburgh Molecular Imaging Ltd.. (12/17/19). "Press Release: Edinburgh Molecular Imaging Closes Financing". Edinburgh. 2019-12-17
GlaxoSmithKline plc. (12/16/19). "Press Release: Pivotal DREAMM-2 Study Demonstrated a Clinically Meaningful Overall Response Rate with Belantamab Mafodotin (GSK2857916) for Patients with relapsed/refractory Multiple Myeloma". London. 2019-12-16
Sidekick Health. (12/16/19). "Press Release: Sidekick Partners with Bayer to Provide Digital Therapy Expansion for PAD Patients". 2019-12-16
Genmab A/S. (12/13/19). "Press Release: CHMP Issues Positive Opinion Recommending Darzalex (Daratumumab) in Combination with Bortezomib, Thalidomide and Dexamethasone in Frontline Multiple Myeloma". Copenhagen. 2019-12-13
Immunicum AB. (12/13/19). "Press Release: Immunicum AB (publ) Announces Resignation of Carlos de Sousa as CEO". 2019-12-13
Start Codon Ltd.. (12/11/19). "Press Release: Start Codon and One Nucleus Partner to Support UK Life Science Ecosystem. Start Codon Cohort Companies to Receive One Nucleus Membership Benefits". Cambridge. 2019-12-11
Markes International Ltd.. (12/10/19). "Press Release: Markes Becomes Licensed World Commercial Supplier of Thin-Film Solid-Phase Microextraction (TF-SPME)". 2019-12-10
Charles River Laboratories International, Inc.. (12/10/19). "Press Release: Charles River Announces Strategic Partnership with Bit Bio, Increasing Portfolio of Translational Drug Discovery Technologies". Wilmington, MA. 2019-12-10
Owlstone Medical Ltd.. (12/10/19). "Press Release: Owlstone Medical to Join EU-Funded EPHOR Consortium to Advance Occupational Health Science in Order to Reduce Disease Burden from Workplace Exposure". Cambridge. 2019-12-10
Epidarex Capital. (12/9/19). "Press Release: Epidarex Exeed Founded by Epidarex Capital to Advance Early Stage, Highly Innovative Life Science Assets". Edinburgh. 2019-12-09
Jasper Therapeutics, Inc.. (12/6/19). "Press Release: Jasper Therapeutics Launches with $35 Million Series A Financing to Develop and Commercialize Innovative Conditioning Agents and Therapies to Transform Curative Hematopoietic Cell Transplants". Palo A 2019-12-06
Ferring Pharmaceuticals S.A.. (12/5/19). "Press Release: FerGene Announces Pivotal Phase 3 Study of Nadofaragene Firadenovec Met Its Primary Endpoint". Washington, DC. 2019-12-05
Unibio International plc. (12/4/19). "Press Release: Mitsubishi Corporation Invests in, and Partners with, Unibio". London & Copenhagen. 2019-12-04
Owkin. (12/2/19). "Press Release: Owkin Teams up with NVIDIA and King's College London to Deliver AI to Hospitals While Protecting Patient Data With Federated Learning". Paris & New York. 2019-12-02
Lunac Therapeutics Ltd.. (12/2/19). "Press Release: Lunac Therapeutics Led Project Awarded £3.14 Million under Innovate UK Biomedical Catalyst Programme, to Develop Next-generation Anticoagulant". Leeds. 2019-12-02
Oncopeptides AB. (12/2/19). "Press Release: Oncopeptides Appoints Joseph Horvat as President North America". Stockholm. 2019-12-02
CureVac AG. (12/2/19). "Press Release: CureVac Granted Manufacturing Authorization for Its Third GMP Production Suite". Tübingen & Boston, MA. 2019-12-02
Markes International Ltd.. (11/28/19). "Press Release: New Appointment Signals Asia Pacific Market Growth for Markes International". 2019-11-28
Novo Holdings A/S. (11/26/19). "Press Release: Novo Seeds Expands Company Formation Activities at BiOrigin with Seasoned Entrepreneurs". Copenhagen. 2019-11-26
Asahi Kasei Corporation. (11/25/19). "Press Release: Presentation – Accelerating Transformation into a Global Health Care Company. Acquisition of U.S.-based Veloxis Pharmaceuticals Inc.". Tokyo. 2019-11-25
Alkermes plc. (11/25/19). "Press Release: Alkermes Completes Acquisition of Rodin Therapeutics". Dublin. 2019-11-25
Asahi Kasei Corporation. (11/25/19). "Press Release: Asahi Kasei to Acquire Veloxis Pharmaceuticals Inc. to Accelerate Transformation into a Global Health Care Company". Tokyo. 2019-11-25
GeNeuro S.A.. (11/25/19). "Press Release: GeNeuro and the Karolinska Institutet/Academic Specialist Center of Stockholm Agree to Launch a New Clinical Study of Temelimab in Multiple Sclerosis". Geneva. 2019-11-25
Veloxis Pharmaceuticals A/S. (11/25/19). "Press Release: Asahi Kasei Group Announces a Recommended Conditional Voluntary Public Offer for Veloxis [Not for any jurisdiction where violation of law]". Copenhagen. 2019-11-25
Azeria Therapeutics Ltd.. (11/21/19). "Press Release: Azeria Therapeutics Announces £32.0 million Series B Financing". London. 2019-11-21
GHO Capital Partners LLP. (11/20/19). "Press Release: GHO Capital Raises €975m in Largest Ever European Healthcare Fund". London. 2019-11-20
Sangamo Therapeutics, Inc.. (11/19/19). "Press Release: Sangamo Announces UK Authorization of a Phase 1/2 Clinical Trial Evaluating the CAR-Treg Cell Therapy TX200 for Kidney Transplantation". Brisbane, CA. 2019-11-19
Zelluna Immunotherapy AS. (11/19/19). "Press Release: Zelluna Immunotherapy and Glycostem Therapeutics Announce Partnership to Develop Allogeneic TCR-NK Therapies". Oslo & Oss. 2019-11-19
Causaly Ltd.. (11/19/19). "Press Release: Causaly Raises $5m in Series A Round Led by Pentech Ventures". London. 2019-11-19
Rodin Therapeutics Inc.. (11/18/19). "Press Release: Alkermes to Acquire Rodin Therapeutics". Dublin & Boston, MA. 2019-11-18
Savara Inc.. (11/18/19). "Press Release: Savara Appoints Badrul Chowdhury, M.D., Ph.D as Chief Medical Officer". Austin, TX. 2019-11-18
Novo Nordisk A/S. (11/18/19). "Press Release: Dicerna and Novo Nordisk Enter Agreement to Discover and Develop RNAi Therapies for Liver-related Cardio-metabolic Diseases". Lexington, MA & Bagsvaerd. 2019-11-18
Okra Technologies Ltd.. (11/15/19). "Press Release: Okra Becomes a Veeva Technology Partner". Cambridge. 2019-11-15
Fujifilm Corporation. (11/14/19). "Press Release: Fujifilm Announces Expansion of its Biopharmaceutical Contract Development and Manufacturing Business". Tokyo. 2019-11-14
Lunac Therapeutics Ltd.. (11/14/19). "Press Release: Lunac Therapeutics Spun Out to Develop Next Generation Anticoagulants, and Announces Series A Funding Round". Leeds. 2019-11-14
Avacta Group plc. (11/13/19). "Press Release: LG Chem Life Sciences Expands Partnership with Avacta". 2019-11-13
Turbine Kft.. (11/13/19). "Press Release: Turbine Secures €3 Million Seed Fund to Expand the Potential of Simulation-first Drug discovery". London & Budapest. 2019-11-13
Innate Pharma S.A.. (11/13/19). "Press Release: Innate Pharma Third Quarter 2019 Report". 2019-11-13
Bavarian Nordic A/S. (11/13/19). "Press Release: Bavarian Nordic Announces Appointment of Jean-Christophe May as Executive Vice President and Chief Commercial Officer". Copenhagen. 2019-11-13
Expedeon AG. (11/11/19). "Press Release: Expedeon AG Signs EUR 120 Million Deal with Abcam for the Sale of Its immunology and Proteomics Business". Heidelberg & Cambridge. 2019-11-11
Waters Corporation. (11/7/19). "Press Release: World’s First Cyclic IMS Mass Spectrometer Installed at Aston University". Milford, MA. 2019-11-07
Owlstone Medical Ltd.. (11/7/19). "Press Release: Owlstone Medical Enters Partnership with Thermo Fisher Scientific to Advance Early Disease Detection Using Non-invasive Breath Biopsy". Cambridge. 2019-11-07
Rentschler Biopharma SE. (11/6/19). "Press Release: Rentschler Biopharma Kicks off Expansion at U.S. Facility in the Boston Biotech Hub". Laupheim & Milford, MA. 2019-11-06
Ervaxx Ltd.. (11/6/19). "Press Release: Ervaxx Launches to Pioneer the Use of Dark Antigens for the Development of Off-the-Shelf Cancer Vaccines and T-cell Receptor-based Immunotherapies". London. 2019-11-06
Greenough. (11/6/19). "Press Release: Agencies Align Life Science/Healthcare Expertise to Offer Integrated Marketing Services on Both Sides of the Pond". Watertown, MA. 2019-11-06
AstraZeneca plc. (11/6/19). "Press Release: AstraZeneca Announces Three Large-scale Initiatives in China to Advance Global Medicine Research and Development". 2019-11-06
Artios Pharma Ltd.. (11/6/19). "Press Release: Artios Pharma, MD Anderson and ShangPharma Announce In-licensing Agreement for DNA Damage Response Inhibitor". Cambridge, New York, NY, Houston, TX & South San Franicsco, CA. 2019-11-06
Zelluna Immunotherapy AS. (11/4/19). "Press Release: Zelluna Immunotherapy Appoints Dr Bent Jakobsen, a Pioneer of TCR Therapeutics, to the Board of Directors". Oslo. 2019-11-04
Mesa Laboratories, Inc.. (10/31/19). "Press Release: Mesa Labs Acquires Gyros Protein Technologies". Lakewood, CO. 2019-10-31
Bicycle Therapeutics plc. (10/31/19). "Press Release: Bicycle Therapeutics Announces Appointment of Veronica Jordan, Ph.D., to Board of Directors". Cambridge & Boston, MA. 2019-10-31
AstraZeneca plc. (10/30/19). "Press Release: AstraZeneca Divests Rights to Seroquel and Seroquel XR in Europe and Russia". 2019-10-30
Genmab A/S. (10/30/19). "Press Release: David Eatwell to Retire as Chief Financial Officer of Genmab". Copenhagen. 2019-10-30
Disc Medicine. (10/29/19). "Press Release: Disc Medicine Completes $50 Million Series A Financing led by Novo Holdings A/S to Advance New Therapies Addressing Ineffective Red Blood Cell Production". Cambridge, MA. 2019-10-29
Bicycle Therapeutics plc. (10/29/19). "Press Release: Bicycle Therapeutics Announces Appointment of Nigel Crockett, Ph.D., as Chief Business Officer". Cambridge & Boston, MA. 2019-10-29
Parc Cientific de Barcelona (BCP, Barcelona Science Park Foundation). (10/28/19). "Press Release: Molomics Opens an Investment Round to Accelerate an Innovative Project against Parkinson’s". Planegg & Mechelen. 2019-10-28
AstraZeneca plc. (10/24/19). "Press Release: Year-to-Date and Q3 2019 Results". 2019-10-24
H. Lundbeck A/S. (10/22/19). "Press Release: Lundbeck Completes the Acquisition of Alder BioPharmaceuticals – a Company Committed to Transforming Migraine Treatment and Prevention". Valby. 2019-10-22
Bicycle Therapeutics plc. (10/22/19). "Press Release: Bicycle Therapeutics Expands Neuroscience Collaborations to include Oxford University’s Oxford Drug Discovery Institute". Cambridge & Boston, MA. 2019-10-22
Zealand Pharma A/S. (10/22/19). "Press Release: Zealand Pharma Expands Its Peptide Platform with Acquisition of Encycle Therapeutics". Copenhagen. 2019-10-22
Arnold & Porter LLP. (10/22/19). "Press Release: Life Sciences Lawyer and Former EMA Legal Adviser Alexander Roussanov Joins Arnold & Porter in Brussels". Brussels. 2019-10-22
CRISPR Therapeutics AG. (10/21/19). "Press Release: CRISPR Therapeutics and Bayer Announce an Update on Casebia Therapeutics". Leverkusen, Zug & Cambridge, MA. 2019-10-21
Bavarian Nordic A/S. (10/21/19). "Press Release: Bavarian Nordic Announces a Transformative Acquisition of Two Established Commercial Vaccines from GlaxoSmithKline". Copenhagen. 2019-10-21
Cancer Research UK. (10/21/19). "Press Release: International Alliance Sets Bold Research Ambition to Detect the (almost) Undetectable". 2019-10-21
ReViral Ltd.. (10/21/19). "Press Release: ReViral Announces Appointment of Alan Musso as Chief Financial Officer". London. 2019-10-21
Avacta Group plc. (10/18/19). "Press Release: Proposed Placing and Subscription to Raise up to £9 Million and Notice of General Meeting". 2019-10-18
BC Platforms. (10/17/19). "Press Release: BC Platforms Partners with Blueprint Genetics to Provide Center of Excellence for Data Driven Testing Services in Rare Diseases". Zürich & Boston, MA. 2019-10-17
GammaDelta Therapeutics Ltd.. (10/16/19). "Press Release: Adaptate Biotherapeutics Formed to Develop Antibody-based Therapies that Modulate Gamma Delta T-cells". London. 2019-10-16
Amarna Therapeutics B.V.. (10/16/19). "Press Release: Amarna Therapeutics Raises €10 Million to Progress Lead Development Candidate into Clinical Trials and Appoints a New Supervisory Board". Leiden. 2019-10-16
Healx Ltd.. (10/16/19). "Press Release: Healx Secures $56m in Series B Financing, Launches Global Accelerator Programme for Rare Diseases". Cambridge. 2019-10-16
Bit Bio Ltd.. (10/15/19). "Press Release: Elpis Becomes Bit Bio. We Are Excited to Announce Our Transition to the Cell Coding Company!". 2019-10-15
Cell Mogrify Ltd.. (10/14/19). "Press Release: Mogrify Raises Additional $16 Million to Advance Its Mission to Transform the Development of Life-saving Cell Therapies". Cambridge. 2019-10-14
Evotec SE. (10/10/19). "Press Release: Just-Evotec Biologics and Biocon Biologics Sign Licensing Deal for a Biosimilar Asset". Hamburg, Seattle, WA & Bengaluru. 2019-10-10
Biofidelity Ltd.. (10/10/19). "Press Release: Biofidelity Awarded Innovate UK Grant to Develop Non-Invasive Tests to Enable Precision Medicine". Cambridge. 2019-10-10
Bayer AG. (10/10/19). "Press Release: Bayer Launches LifeHub UK Focused on Artificial Intelligence to Optimize Data-driven Drug discovery and Disease Diagnosis". Leverkusen & Reading. 2019-10-10
Agilent Technologies Inc.. (10/9/19). "Press Release: Agilent Opens State-of-the-Art Spectroscopy Site in the UK". Santa Clara, CA. 2019-10-09
1 2 3 ... 48 49 50  next pagenext page



Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 650x65px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Advertisement

Picture Kentro Design Corporate and Web Design Berlin 650x65px

» top